Cargando…
An LPAR(5)-antagonist that reduces nociception and increases pruriception
INTRODUCTION: The G-protein coupled receptor LPAR(5) plays a prominent role in LPA-mediated pain and itch signaling. In this study we focus on the LPAR(5)-antagonist compound 3 (cpd3) and its ability to affect pain and itch signaling, both in vitro and in vivo. METHODS: Nociceptive behavior in wild...
Autores principales: | Langedijk, Jacqueline, Araya, Erika Ivanna, Barroso, Amanda Ribeiro, Tolenaars, Dagmar, Nazaré, Marc, Belabed, Hassane, Schoene, Jens, Chichorro, Juliana Geremias, Oude Elferink, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360597/ https://www.ncbi.nlm.nih.gov/pubmed/35959236 http://dx.doi.org/10.3389/fpain.2022.963174 |
Ejemplares similares
-
Editorial: Women in science: pharmacological treatment of pain
por: Araya, Erika Ivanna, et al.
Publicado: (2023) -
Editorial: Chronic orofacial pain
por: Kopruszinski, Caroline Machado, et al.
Publicado: (2023) -
Trigeminal Neuralgia: Basic and Clinical Aspects
por: Araya, Erika Ivanna, et al.
Publicado: (2020) -
Small-Molecule Lysophosphatidic Acid Receptor 5 (LPAR5) Antagonists: Versatile Pharmacological Tools to Regulate Inflammatory Signaling in BV-2 Microglia Cells
por: Plastira, Ioanna, et al.
Publicado: (2019) -
Reduced spontaneous itch in mouse models of cholestasis
por: Langedijk, Jacqueline, et al.
Publicado: (2021)